These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 20440215)
1. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K Acta Ophthalmol; 2010 Feb; 88(1):96-102. PubMed ID: 19775309 [TBL] [Abstract][Full Text] [Related]
3. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. Alkawas AA; Shahien EA; Hussein AM J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643 [TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma. Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201 [TBL] [Abstract][Full Text] [Related]
6. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594 [TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma. Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888 [TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Kitnarong N; Chindasub P; Metheetrairut A Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438 [TBL] [Abstract][Full Text] [Related]
9. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Takihara Y; Inatani M; Fukushima M; Iwao K; Iwao M; Tanihara H Am J Ophthalmol; 2009 May; 147(5):912-8, 918.e1. PubMed ID: 19195639 [TBL] [Abstract][Full Text] [Related]
10. Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis. Nakatake S; Yoshida S; Nakao S; Arita R; Yasuda M; Kita T; Enaida H; Ohshima Y; Ishibashi T BMC Ophthalmol; 2014 Apr; 14():55. PubMed ID: 24766841 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917 [TBL] [Abstract][Full Text] [Related]
12. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma. Sevim MS; Buttanri IB; Kugu S; Serin D; Sevim S Ophthalmologica; 2013; 229(2):94-100. PubMed ID: 23364308 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial. Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients. Cornish KS; Ramamurthi S; Saidkasimova S; Ramaesh K Eye (Lond); 2009 Apr; 23(4):979-81. PubMed ID: 18451875 [TBL] [Abstract][Full Text] [Related]
15. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Zhou MW; Wang W; Huang WB; Chen SD; Li XY; Gao XB; Zhang XL Chin Med J (Engl); 2013; 126(8):1412-7. PubMed ID: 23595369 [TBL] [Abstract][Full Text] [Related]
16. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma. Sahyoun M; Azar G; Khoueir Z; Antoun J; Kourie H; Nehme J; Jalkh A J Glaucoma; 2015; 24(5):383-8. PubMed ID: 25719230 [TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure following combined routes of bevacizumab-augmented trabeculectomy for refractory neovascular glaucoma. Chatterjee S; Rao A Semin Ophthalmol; 2013 Mar; 28(2):72-4. PubMed ID: 23448559 [TBL] [Abstract][Full Text] [Related]
18. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Nilforushan N; Yadgari M; Kish SK; Nassiri N Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106 [TBL] [Abstract][Full Text] [Related]
19. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma. Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654 [TBL] [Abstract][Full Text] [Related]
20. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]